Clinical Trials
74 trialsHER2 CR
Nagoya City University
REFLECT
University Health Network, Toronto
Harvesting Cells for Experimental Cancer Treatments
National Institutes of Health Clinical Center (CC)
CER
Cancer Support Community, Research and Training Institute, Philadelphia
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
University of Maryland, Baltimore
Diagnostic Performance of 18F-FDG PET/CT in Detecting Distant Metastases in Breast Cancer
Assiut University
REGISTEM
Spanish Breast Cancer Research Group
L2-268
European Institute of Oncology
PROVIDENCE
AstraZeneca
RESONATE
Novartis
PDM-MBC
The Christie NHS Foundation Trust
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Pfizer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
Hellenic Cooperative Oncology Group
NIR-II
Yunnan Cancer Hospital
Artificial Intelligence Model-Assisted Accurate Diagnosis of Early-Stage Breast Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
START
Lyell Immunopharma, Inc.
EpCAM-Targeted Surface-Enhanced Raman Spectroscopy Nanotags for Rapid Evaluation of Surgical Margins and Sentinel Lymph Node Metastasis Status in Breast Cancers
Yunnan Cancer Hospital
Integrin αvβ6-targeted PET in Malignant Tumors
Zhongnan Hospital
Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment
Chinese University of Hong Kong
PALMARES-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
NIR-II
Yunnan Cancer Hospital
The Impact of Radiotherapy on Oligometastatic Cancer
Institut Investigacio Sanitaria Pere Virgili
CCR4-NOT
Ain Shams University
SONABRE
Academisch Ziekenhuis Maastricht
Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study
Tongji Hospital
Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
MINDACTRelapse
European Organisation for Research and Treatment of Cancer - EORTC
BIO-META
Consorzio Oncotech
Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer
City of Hope Medical Center
HOMING
Angle plc
CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer
RenJi Hospital
COMET
UNICANCER
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
Jewish General Hospital
SPACE2
Weprom
Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer
Ankara Oncology Research and Training Hospital
E-SPEC
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
RAPANK
Centre Leon Berard
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
First Hospital of China Medical University
PIONEER
SpeciCare
IMET
Federation of Breast Diseases Societies
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
SWOG Cancer Research Network
COP-BREAST
Seoul National University Hospital
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
University Health Network, Toronto
A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
Genentech, Inc.
Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
Unity Health Toronto
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
National Institutes of Health Clinical Center (CC)
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Latin American Cooperative Oncology Group
MAP-IT
Yale University
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
M.D. Anderson Cancer Center